SGLT2 INHIBITORS AND MYOCARDIAL REMODELING IN PROSTATE CANCER PATIENTS: THE ROLE OF SPECKLE TRACKING ECHOCARDIOGRAPHY (GLS). NUJM 2025, 1 (3), 71-76.